MOLECULAR PRECISION, CLINICAL CONFIDENCE
LIVE

Serial Number

99723607

Owner

Collidion, Inc.

Attorney

Dean G. Stathakis

Filing Date

Mar 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

MOLECULAR PRECISION, CLINICAL CONFIDENCE Trademark

Serial Number: 99723607

MOLECULAR PRECISION, CLINICAL CONFIDENCE is a trademark filed by Collidion, Inc. on March 25, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Collidion, Inc. (17 trademarks)

Petaluma, CA 94954

Entity Type: 03

Trademark Details

Filing Date

March 25, 2026

Registration Date

Not Registered

Goods & Services

Antimicrobial preparations for preventing , inhibiting, or reducing growth of microbes and spores; Antimicrobial preparations for preventing , inhibiting, OR reducing growth of bacteria, viruses, fungi, and mold, and spores of bacteria, viruses, fungi, and mold; Antimicrobial preparations for treating and preventing microbial infections; Antimicrobial preparations for treating and preventing bacterial, viral, and fungal infections; Antimicrobial preparations for treating wounds and microbial infections; Antimicrobial preparations for treating wounds and bacterial, viral, and fungal infections; Antibacterial pharmaceuticals; Disinfectants; All purpose disinfectants; All purpose disinfectants for reducing, inhibiting, or preventing growth of microbes and spores; All purpose disinfectants for reducing, inhibiting, or preventing growth of viruses, bacteria, fungi, molds, and other microbes and spores of viruses, bacteria, fungi, molds, and other microbes; Disinfectants for medical instruments; Medical cleansers for skin and wounds; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment and prevention of wounds and microbial infections; Pharmaceutical preparations for the treatment and prevention of wounds and bacterial, viral, and fungal infections

Pharmaceutical products development; Research and development of new products in the field of pharmaceuticals

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Aug 12, 2026 CNRT
ASSIGNED TO EXAMINER
Aug 5, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 4, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 25, 2026 MAFR
NEW APPLICATION ENTERED
Mar 25, 2026 NWAP